Related Experiment Video
Updated: Dec 6, 2025

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
Abstract:
Emmanuelle Charpentier, PhD, and Jennifer Doudna, PhD, who pioneered the site-specific CRISPR gene-editing technology that has revolutionized cancer research and treatment, were awarded the 2020 Nobel Prize in Chemistry. Many CRISPR-based therapies are already in human testing, with gene-edited T cells for blood cancers and solid tumors leading the way.
Insights
CRISPR gene-editing technology, pioneered by Nobel laureates, is revolutionizing cancer research and treatment. Gene-edited T cell therapies are advancing rapidly in human trials for various cancers.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- CRISPR gene-editing technology, a site-specific DNA modification tool, has emerged as a revolutionary force in biomedical research.
- The pioneering work of Emmanuelle Charpentier and Jennifer Doudna in developing CRISPR technology earned them the 2020 Nobel Prize in Chemistry.
Discussion:
- CRISPR-based therapies are demonstrating significant potential in clinical applications, particularly in oncology.
- The technology's precision allows for targeted genetic modifications, offering new avenues for treating complex diseases.
Key Insights:
- Gene-edited T cells are at the forefront of CRISPR-based cancer therapies currently undergoing human testing.
- These advanced therapies are being developed for both hematological malignancies and solid tumors.
Outlook:
- The ongoing clinical trials signify a critical phase in translating CRISPR technology from laboratory discovery to patient treatment.
- CRISPR gene editing holds immense promise for the future of personalized medicine and the development of novel cancer therapeutics.
Related Concept Videos
CRISPR
CRISPR/Cas9 Genome Editing
Homologous Recombination
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The Antiviral System of Bacteria and Archaea: CRISPR
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

